Security
Palomino Laboratories Inc. · PRE_1938569
PRE_1938569UNKNOWNotherCurrentCIK 1938569Updated Oct 15, 2026
Name history
Unite Acquisition 3 Corp. · through Aug 29, 2025
PRE_1938569 price & chart
Venue mapping has not been verified.
About the company
Palomino is a fabless semiconductor company pioneering the next generation of high-performance microLED-based optoelectronic solutions for data communication. Its mission is to enable ultra-high-speed, energy-efficient optical interconnects that replace legacy copper-based PCIe and Ethernet links in compute-intensive environments. Palomino is commercializing a breakthrough platform built on advanced gallium nitride (GaN) compound semiconductor materials. This proprietary technology enables scalable and cost-efficient manufacturing of ultra-compact, high-speed optical transceivers, with significant improvements in power, size, and bandwidth density over traditional laser-based solutions. Palomino’s differentiated value proposition lies in leveraging high-efficiency microLEDs as optical sources in transceiver modules that can be seamlessly integrated into silicon packages or interposers. This approach unlocks the potential for high-density, chip-scale optical I/O—fundamentally reshaping the future of data movement in AI servers, data centers, and high-performance computing systems.
In the news
No coverage from other publishers is available.
Recent filings
Financial Statements and Exhibits
Items 9.01
DEF 14A filing
PRE 14A filing
SCHEDULE 13D/A - filed by Ogawa Richard regarding Palomino Laboratories Inc.
Entry into a Material Definitive Agreement · Completion of Acquisition or Disposition of Assets · Regulation FD Disclosure
Items 1.01, 2.01, 7.01, 9.01
Show 5 more recent filings
10-Q filing
4 filing
Entry into a Material Definitive Agreement · Regulation FD Disclosure
Items 1.01, 7.01, 9.01
10-Q filing
Unregistered Sales of Equity Securities
Items 3.02, 9.01
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 8,312,761Source | 322Source | 21,042,166Source | 1,887Source | 322Source | 7,361,705Source | 18,220Source | 380Source | 8,434,145Source | 29,180Source | 380Source | 500Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 7,896,569Source | — | 19,444,793Source | — | — | 6,656,641Source | — | 380Source | 8,121,445Source | — | 380Source | 500Source |
| Assets, CurrentUSD | — | 322Source | 19,593,359Source | 1,887Source | 322Source | 6,825,501Source | 18,220Source | 380Source | 8,434,145Source | 29,180Source | 380Source | 500Source |
| Prepaid Expense and Other Assets, CurrentUSD | 416,192Source | — | 148,566Source | — | — | 168,860Source | — | — | 312,700Source | — | — | — |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 999,013Source | 221,754Source | 475,962Source | 364,431Source | 194,658Source | 351,970Source | 336,989Source | 162,925Source | 336,458Source | 286,287Source | 111,621Source | 27,804Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 1,761Source | 500Source | 2,316Source | 500Source | 500Source | 1,892Source | 500Source | 500Source | 1,877Source | 500Source | 500Source | 500Source |
| Additional Paid in CapitalUSD | 9,750,942Source | — | 26,353,914Source | — | — | 11,432,835Source | — | — | 11,277,372Source | — | — | — |
| Retained Earnings (Accumulated Deficit)USD | -2,438,955Source | -221,932Source | -5,790,026Source | -363,044Source | -194,836Source | -4,424,992Source | -319,269Source | -163,045Source | -3,181,562Source | -257,607Source | -111,741Source | -27,804Source |
| Stockholders' Equity Attributable to ParentUSD | 7,313,748Source | -8,343Source | 20,566,204Source | -447,236Source | -194,336Source | 7,009,735Source | -991,653Source | -162,545Source | 8,097,687Source | -257,107Source | -111,241Source | -27,304Source |
| Liabilities and EquityUSD | 8,312,761Source | 322Source | 21,042,166Source | 1,887Source | 322Source | 7,361,705Source | 18,220Source | 380Source | 8,434,145Source | 29,180Source | 380Source | 500Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 999,013Source | 221,754Source | 368,885Source | 364,431Source | 194,658Source | 228,862Source | 336,989Source | 162,925Source | 336,458Source | 286,287Source | 111,621Source | 27,804Source |
| Accounts Payable, CurrentUSD | 60,952Source | — | 162,473Source | — | — | 87,157Source | — | — | 55,687Source | — | — | — |
| Property, Plant and Equipment, Net | — | — | —Source | — | — | —Source | — | — | — | — | — | — |
| Operating Lease, Right-of-Use Asset | — | — | —Source | — | — | —Source | — | — | — | — | — | — |
| Operating Lease, Liability, Current | — | — | —Source | — | — | —Source | — | — | — | — | — | — |
| Operating Lease, Liability, Noncurrent | — | — | —Source | — | — | —Source | — | — | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | — | — | 83,937Source | — |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | 1,256,750Source | — | 100,528Source | 155,000Source | — | — | 1,441,823Source | — | — | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -1,116,468Source | 3,052Source | -1,284,949Source | -166,637Source | -79,379Source | — |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | -30,000Source | 20Source | 9,271,737Source | 195,437Source | 79,259Source | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -1,464,804Source | 3,072Source | 7,986,788Source | — | — | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 7,896,569Source | 140,357Source | 19,444,793Source | 1,723,646Source | 6,656,641Source | 137,729Source | 8,121,445Source | 29,180Source | 380Source | 500Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | — | 58Source | — | — |
| Additional Financial Items | ||||||||||||
| General and Administrative ExpenseUSD | — | — | 1,604,922Source | 1,234Source | 696,635Source | 337,445Source | 805,363Source | 17,828Source | 2,702,834Source | 140,080Source | 83,937Source | — |
| InterestExpenseNonoperatingUSD | — | — | — | — | — | 8,227Source | — | 8,137Source | — | 5,786Source | — | — |
| Investment Income, InterestUSD | — | — | 37Source | 1,350Source | 237Source | 12Source | 173Source | 809Source | 890Source | — | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -1,824,837Source | -6,334Source | -1,365,034Source | 389,417Source | -1,243,430Source | -985,169Source | -3,163,196Source | -145,866Source | -83,937Source | — |
| Operating ExpensesUSD | — | — | 1,604,922Source | 1,234Source | 1,365,271Source | 337,445Source | 1,243,603Source | 17,828Source | 2,702,834Source | — | — | — |
| Depreciation, Depletion and Amortization | — | — | — | — | — | — | —Source | — | — | — | — | — |
| Increase (Decrease) in Accounts Payable | — | — | — | — | — | — | —Source | —Source | — | — | — | — |
| Net Cash Provided by (Used in) Investing Activities | — | — | — | — | — | — | —Source | — | — | — | — | — |
| Depreciation | — | — | — | — | —Source | — | —Source | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income (Loss)USD | — | — | -1,604,922Source | -1,234Source | -1,365,271Source | -337,445Source | -1,243,603Source | -17,828Source | -2,702,834Source | -140,080Source | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -1,824,837Source | -6,334Source | -1,365,034Source | 389,417Source | -1,243,430Source | -985,169Source | -3,163,196Source | -145,866Source | -83,937Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.54Source | 0Source | -0.06Source | 0.15Source | -0.07Source | -0.44Source | -0.47Source | -0.03Source | -0.02Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.54Source | 0Source | -0.06Source | 0.15Source | -0.07Source | -0.44Source | -0.47Source | -0.03Source | -0.02Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 3,383,919Source | 1,662,024Source | 21,818,476Source | 2,584,135Source | 18,512,351Source | 2,225,000Source | 6,710,995Source | 5,000,000Source | 5,000,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 3,383,919Source | 1,662,024Source | 21,818,476Source | 2,584,135Source | 18,512,351Source | 2,225,000Source | 6,710,995Source | 5,000,000Source | 5,000,000Source |
| Interest Expense (non-operating)USD | — | — | — | — | — | 8,227Source | — | 8,137Source | — | 5,786Source | — |
| Additional Financial Items | |||||||||||
| General and Administrative ExpenseUSD | — | — | 1,604,922Source | 1,234Source | 696,635Source | 337,445Source | 805,363Source | 17,828Source | 2,702,834Source | 140,080Source | 83,937Source |
| Interest Expense, DebtUSD | — | — | — | — | — | 8,227Source | — | 13,923Source | — | 5,786Source | — |
| Investment Income, InterestUSD | — | — | 37Source | 1,350Source | 237Source | 12Source | 173Source | 809Source | 890Source | — | — |
| Operating ExpensesUSD | — | — | 1,604,922Source | 1,234Source | 1,365,271Source | 337,445Source | 1,243,603Source | 17,828Source | 2,702,834Source | — | — |
| Other ExpensesUSD | — | — | 975Source | 1,234Source | — | — | — | — | 71,519Source | — | — |
| Research and Development Expense | — | — | — | — | —Source | — | —Source | — | — | — | — |
Offerings
Registration 333-292890
Filing attachments
ex99-1.htm · 8-K/A · 2026-10-14
Exhibit 99.1 VEGA LINKS, INC. FINANCIAL STATEMENTS FOR THE PERIOD FROM JANUARY 21, 2026 (INCEPTION) THROUGH JULY 30, 2026 INDEX TO FINANCIAL STATEMENTS Statement Page Independent Auditor’s Report 1 Balance Sheet as of July 30, 2026 2 …
Read attachment ↗ex99-2.htm · 8-K/A · 2026-10-14
Exhibit 99.2 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS Introduction On July 31, 2026, Palomino Laboratories Inc. (“Palomino” or the “Company”) entered into a Share Exchange Agreement and Plan of Reorganization (the “Share Exchange Agreement”) with Vega Links, Inc. (“Vega Links” or “VLI”) and the stockholders of Vega Links (the “Stockholders”), pursuant to which the Stockholders transferred to the Company 100% of the issued and outstanding shares of Vega Links common stock (t…
Read attachment ↗ex99-1.htm · 8-K · 2026-08-05
EX-99.1 3 ex99-1.htm EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE Palomino Laboratories Completes Vega Links Acquisition and Strengthens Technology Leadership to Accelerate Next-Generation AI Interconnect Development Strategic Company Highlights: (i) Successfully closed the Vega Links acquisition, transforming Palomino into a comprehensive AI interconnect company and expanding the Company’s estimated addressable market by approximately 10x to greater than…
Read attachment ↗ex99-1.htm · 8-K · 2026-07-16
EX-99.1 3 ex99-1.htm EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE Palomino Laboratories Announces Binding LOI to Acquire Vega Links Inc. to Create a Next-Generation AI Interconnect Company Transaction Highlights: (i) Transforms Palomino beyond MicroLED optical interconnects into a comprehensive AI interconnect company spanning copper, MicroVCSEL and MicroLED data communication solutions; (ii) Expand Palomino’s estimated addressable market by 10x—f…
Read attachment ↗ex4-2.htm · 8-K · 2026-05-05
EX-4.2 2 ex4-2.htm EX-4.2 Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ SECURITIES ACT ”). THESE SECURITIES MAY BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED ONLY (A) TO THE COMPANY, (B) IN COMPLIANCE WITH RULE 144 UNDER THE SECURITIES A…
Read attachment ↗ex4-1.htm · 8-K · 2026-04-24
EX-4.1 2 ex4-1.htm EX-4.1 Exhibit 4.1 EXECUTION VERSION SUBSCRIPTION AGREEMENT This Subscription Agreement (this “ Agreement ”) has been entered into by and between the purchaser set forth on the Omnibus Signature Page hereof (the “ Purchaser ”) and Palomino Laboratories Inc., a Delaware corporation (the “ Company ”). R E C I T A L S A. The Company is offering a minimum of 3,750,000 shares of the Company’s common stock, par value $0.0001 per share (“ Common Stock ”), at a purchase price…
Read attachment ↗